Erik Pong

Potent <i>In vitro</i> and <i>In vivo</i> Activity of an Fc-Engineered Anti-CD19 Monoclonal Antibody against Lymphoma and Leukemia

Holly M. Horton, Matthew J. Bernett, Erik Pong et al. · Cancer Research · 2008 · 267 citations · Full text

Inhibition of B cell receptor-mediated activation of primary human B cells by coengagement of CD19 and FcγRIIb with Fc-engineered antibodies

Seung Y. Chu, Igor Voštiar, Sher Karki et al. · Molecular Immunology · 2008 · 148 citations

Adaptive Immune System, Immune Cell Development, Humoral Response +13

Antibody-Mediated Coengagement of FcγRIIb and B Cell Receptor Complex Suppresses Humoral Immunity in Systemic Lupus Erythematosus

Holly M. Horton, Seung Y. Chu, Elizabeth Ortiz et al. · The Journal of Immunology · 2011 · 141 citations

Adaptive Immune System, Humoral Response, Immune Regulation +27

A novel bispecific antibody format enables simultaneous bivalent and monovalent co-engagement of distinct target antigens

Gregory L. Moore, Cristina Bautista, Erik Pong et al. · mAbs · 2011 · 101 citations · Full text

Immunology, Immunodominance, Antigen Processing +16

Reduction of total IgE by targeted coengagement of IgE B-cell receptor and FcγRIIb with Fc-engineered antibody

Seung Y. Chu, Holly M. Horton, Erik Pong et al. · Journal of Allergy and Clinical Immunology · 2012 · 92 citations

Fc-engineered Antibody, Targeted Coengagement, Immunology +12